Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 889-900 of 2,301
Device study icon
TerminatedNCT05551195

Digital Therapeutic for depression

This study was terminated in the United States. It is testing digital Therapeutic for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 45 Years
Countries
United States
Sponsor
Woebot Health
Condition
Depression
Drug study icon
CompletedNCT03460756

A study of Oral Ganaxolone in Women With Postpartum Depression

This study exists to understand whether the medication Oral is both safe enough and useful enough to take further. For people living with Depression, that matters because care needs to work in daily life, not just in theory.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 48 Years
Countries
United States
Sponsor
Marinus Pharmaceuticals
Condition
Depression
Drug study icon
CompletedNCT05550532

Aticaprant 10 Milligrams (mg) for Depression

This study is completed in the United States, in France, in Canada, .... It is testing Aticaprant 10 Milligrams (mg) for Depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT06057012

BRII-296 in Adults With Severe Postpartum Depression (PPD)

This study is completed in the United States. It is testing BRII-296 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Brii Biosciences Limited
Condition
Depression
Behavioral study icon
TerminatedNCT00637494

Mifepristone for depression

This study was terminated in the United States. It is testing mifepristone for depression.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaBehavioralOver 22 Years
Countries
United States
Sponsor
Corcept Therapeutics
Condition
Depression, Schizophrenia
Drug study icon
CompletedNCT02942004

SAGE-547 for depression

This study is completed in the United States. It is testing SAGE-547 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT02942017

Safety study of Safety and Efficacy of SAGE-547 in depression

This study is completed in the United States. It is testing Safety and Efficacy of SAGE-547 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT02614547

SAGE-547 in people with Severe Postpartum Depression

This study is completed in the United States. It is testing SAGE-547 for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 45 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
Depression
Other study type icon
CompletedNCT06117397

A Text Messaging Intervention to Reduce Perinatal Depression Risk

This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can give earlier or clearer feedback during care.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionOtherFrom 16 Years to 45 Years
Countries
United States
Sponsor
University of Massachusetts, Worcester
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.